With the proven contribution of zebrafish larval and embryonic models to the study of liver diseases and inflammatory bowel diseases (Goessling and Sadler, 2015; Love et al., 2007), the zebrafish mecp2-null mutant might be ideally suited to illuminating the role of inflammation in the GI tract of RTT patients. This evidence concerns the gene MECP2 and liver disorder.